Secondary Logo

March/April 2019 - Volume 42 - Issue 2
pp: 23-65

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.


A Case of Schizophrenia With Catatonia Resistant to Lorazepam and Olanzapine Monotherapy But Responsive to Combination Treatment: Is It Time to Consider Using Select Second-Generation Antipsychotics Earlier in the Treatment Algorithm for This Patient Type?

Spiegel, David R.; Glad, Rachel; Smith, Melanie; More

Clinical Neuropharmacology. 42(2):57-59, March/April 2019.